ADPKD New Updates
Urine Osmolality Is a Potential Marker of Longer-Term Efficacy of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis. Vijay Ivaturi et.al. Kidney360 5: 996–1001, 2024.
- Prevalence of Renal Neoplasia in Autosomal Dominant Polycystic Kidney Disease: Systematic Review and Meta-Analysis. Anna M. Drake et.al. Nephron 2024;148:457–467.
- Biomarkers of Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Ahmad Ghanem et.al. Kidney International Reports (2024).